Haiming Wu

Company: Sanofi

Job title: Medical Device Product Development & Technology Exploration

Seminars:

Panel Discussion: Comparing Gene Therapy Approaches for Wet AMD: Delivery Methods, Targets, & Therapeutic Potential 2:15 pm

How are intravitreal and subretinal delivery methods impacting treatment precision, effectiveness, and patient experience? What are the implications of targeting VEGF suppression versus complement modulation on efficacy and safety? How can we optimize long-term outcomes by addressing durability, immune response, and safety across different gene therapy approaches?Read more

day: Day Two

Drug Delivery Aspects & Device Impacts on Retinal Vascular Treatments 11:30 am

Optimizing dosing strategies, particularly for gene therapy, to support both physician and patient compliance and improve treatment outcomes Refining device aspects to streamline administration and enhance the overall experience for both patients and healthcare providers Addressing CMC challenges to ensure consistent, reliable treatment options that benefit both physicians and patients through improved compliance and satisfactionRead more

day: Day Two